4,301
Participants
Start Date
February 24, 2020
Primary Completion Date
June 22, 2021
Study Completion Date
June 22, 2021
Radium-223 dichloride (Xofigo, BAY88-8223)
Follow clinical administration
Multiple Locations, Multiple Locations
Lead Sponsor
Bayer
INDUSTRY